Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment
Hailing Tang, Pan Yonghong, Zhang Yu-feng, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 592-605
Closed Access | Times Cited: 18

Showing 18 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 11
Radiocobalt-Labeling of a Polypyridylamine Chelate Conjugated to GE11 for EGFR-Targeted Theranostics
Lorraine Gaenaelle Gé, Mathias Bogetoft Danielsen, Aaraby Nielsen, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 212-212
Open Access
Targeted Delivery of SmacN7 Peptide Induces Immunogenic Cell Death in Cervical Cancer Treatment
Yan Dai, Shentao Lu, Linna Wei, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Three Strategies in Engineering Nanomedicines for Tumor Microenvironment‐Enabled Phototherapy
Shiliang He, Xiao Jia, Sai Feng, et al.
Small (2023) Vol. 19, Iss. 37
Closed Access | Times Cited: 17
Recent advances in peptide-based therapeutic strategies for breast cancer treatment
Ling Li, Gregory J. Duns, Wubliker Dessie, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Peptide-based non-viral gene delivery: A comprehensive review of the advances and challenges
Kai Xiang, Yanan Li, Hailin Cong, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131194-131194
Closed Access | Times Cited: 5
Emerging paradigms and recent progress in targeting ErbB in cancers
Nicolas Stoup, Maxime Liberelle, Nicolas Lebègue, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 552-576
Open Access | Times Cited: 4
Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Hailing Tang, Lijuan Li, Baoshan Wang
AAPS Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Gemcitabine–Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice
Prakash Shrestha, Yashwardhan Ghanwatkar, Sohan Mahto, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 23, pp. 29686-29698
Open Access | Times Cited: 2
Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine): Promising biomedical materials for building stimuli-responsive nanocarriers
Lingcong Zeng, Dandan Kang, Linglin Zhu, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 810-828
Closed Access | Times Cited: 2
Catalyst-free thiazolidine formation chemistry enables the facile construction of peptide/protein–cell conjugates (PCCs) at physiological pH
Xiangquan Liu, Youyu Wang, Bang‐Ce Ye, et al.
Chemical Science (2023) Vol. 14, Iss. 26, pp. 7334-7345
Open Access | Times Cited: 7
Development of light and pH-dual responsive self-quenching theranostic SPION to make EGFR overexpressing micro tumors glow and destroy
Nihan Verimli, S. İrem Goralı, Beyza Abisoglu, et al.
Journal of Photochemistry and Photobiology B Biology (2023) Vol. 248, pp. 112797-112797
Closed Access | Times Cited: 5
Near-infrared-responsive GE11-CuS@Gal nanoparticles as an intelligent drug release system for targeting therapy against oral squamous cell carcinoma
Qing-Hua Lan, Shuanghu Wang, Zhouming Chen, et al.
International Journal of Pharmaceutics (2023) Vol. 649, pp. 123667-123667
Open Access | Times Cited: 5
Nucleolin promotes tumor growth in colorectal cancer by enhancing hnRNPA1-mediated PKM2 alternative splicing
Xue Wang, Han Cheng, Die Hu, et al.
Genes & Diseases (2023) Vol. 10, Iss. 6, pp. 2237-2240
Open Access | Times Cited: 3
EGF‐driven EGFR/miR‐27b‐3p/FOXO1 promotes rat FSH synthesis and secretion
Yi‐Ran Ma, Wei Gao, Hao‐Qi Wang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics
Cibele Rodrigues Toledo, Ahmed A. Tantawy, Leonardo Lima Fuscaldi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8553-8553
Open Access
Ultrasound‐Responsive Lipid Nanoparticles for Targeted Therapy and Controlled Drug Release in Non‐Small Cell Lung Cancer
Min Woo Kim, Sol Moon, Yong Il Park, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 12
Closed Access
Page 1

Scroll to top